Waltham, MA, United States of America

Jing Xu

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations of Jing Xu in Cytokine-Based Therapeutics

Introduction

Jing Xu is an accomplished inventor based in Waltham, MA (US), known for his significant contributions to the field of cytokine-based therapeutics. With a total of 3 patents, his work focuses on developing innovative drug constructs aimed at improving treatment outcomes for various diseases.

Latest Patents

One of his latest patents is centered around a cytokine-based bioactivatable drug construct known as the 'VitoKine' platform. This innovative platform is designed to reduce systemic mechanism-based toxicities while enhancing the therapeutic utility of proteins and cytokines such as IL-15 and IL-2. The VitoKine constructs include a tissue or disease site targeting moiety, a bioactivatable moiety, and a concealing moiety. This design ensures that the active moiety remains inert until activated locally by proteases in diseased tissues, thereby minimizing undesirable toxicities and improving therapeutic efficacy.

Another notable patent involves novel IL-15 fusion proteins that are intended for the treatment of cancer and other disorders. These fusion proteins consist of an IL-15/IL-15RαSushi domain and an Fc domain, which work together to extend the half-life of IL-15 in vivo. This advancement addresses limitations observed in previous IL-15 therapeutics and demonstrates superior preclinical activity compared to existing treatments.

Career Highlights

Jing Xu has worked with prominent companies in the biotechnology sector, including Cugene Inc. and Amgen Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Throughout his career, Jing has collaborated with notable professionals in the field, including Yue-Sheng Li and Lingyun Rui. These collaborations have further enriched his research and development efforts.

Conclusion

Jing Xu's innovative work in cytokine-based therapeutics showcases his commitment to advancing medical science and improving patient outcomes. His patents reflect a deep understanding of the complexities of disease treatment and a dedication to creating safer and more effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…